Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vena Cava Filters | 7 | 2020 | 90 | 0.900 |
Why?
|
| Students, Medical | 2 | 2020 | 455 | 0.860 |
Why?
|
| Embolization, Therapeutic | 6 | 2025 | 279 | 0.850 |
Why?
|
| Vena Cava, Inferior | 7 | 2020 | 143 | 0.810 |
Why?
|
| Career Choice | 2 | 2020 | 163 | 0.680 |
Why?
|
| Carcinoma, Hepatocellular | 5 | 2024 | 426 | 0.680 |
Why?
|
| Device Removal | 6 | 2020 | 166 | 0.630 |
Why?
|
| Medicine | 1 | 2020 | 98 | 0.610 |
Why?
|
| Liver Neoplasms | 5 | 2024 | 793 | 0.580 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2019 | 569 | 0.430 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 682 | 0.420 |
Why?
|
| Prosthesis Implantation | 3 | 2020 | 131 | 0.410 |
Why?
|
| Radiology, Interventional | 3 | 2021 | 66 | 0.360 |
Why?
|
| Radiography, Interventional | 5 | 2020 | 154 | 0.320 |
Why?
|
| Renal Dialysis | 3 | 2021 | 364 | 0.320 |
Why?
|
| Arteriovenous Fistula | 2 | 2021 | 54 | 0.320 |
Why?
|
| Pulmonary Embolism | 3 | 2020 | 235 | 0.300 |
Why?
|
| Catheter Ablation | 2 | 2022 | 266 | 0.300 |
Why?
|
| Yttrium Radioisotopes | 3 | 2024 | 48 | 0.260 |
Why?
|
| Angioplasty | 2 | 2019 | 71 | 0.250 |
Why?
|
| Treatment Outcome | 16 | 2025 | 9173 | 0.250 |
Why?
|
| Tumor Burden | 2 | 2024 | 323 | 0.240 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2021 | 246 | 0.240 |
Why?
|
| Angiography | 3 | 2021 | 209 | 0.240 |
Why?
|
| Ultrasonography, Interventional | 2 | 2024 | 125 | 0.220 |
Why?
|
| Arteriovenous Malformations | 1 | 2025 | 50 | 0.220 |
Why?
|
| Computed Tomography Angiography | 3 | 2021 | 166 | 0.210 |
Why?
|
| Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2024 | 43 | 0.210 |
Why?
|
| Pulmonary Veins | 1 | 2025 | 96 | 0.210 |
Why?
|
| Cholangiocarcinoma | 1 | 2024 | 80 | 0.210 |
Why?
|
| Microspheres | 1 | 2024 | 105 | 0.210 |
Why?
|
| Bile Duct Neoplasms | 1 | 2024 | 91 | 0.210 |
Why?
|
| Hepatectomy | 1 | 2024 | 178 | 0.200 |
Why?
|
| Pulmonary Artery | 1 | 2025 | 341 | 0.190 |
Why?
|
| Radiopharmaceuticals | 1 | 2024 | 204 | 0.190 |
Why?
|
| Chemoembolization, Therapeutic | 1 | 2022 | 32 | 0.190 |
Why?
|
| Workload | 2 | 2020 | 133 | 0.180 |
Why?
|
| Peptic Ulcer Hemorrhage | 1 | 2021 | 10 | 0.180 |
Why?
|
| Surveys and Questionnaires | 2 | 2020 | 2860 | 0.180 |
Why?
|
| Hemostasis, Endoscopic | 1 | 2021 | 16 | 0.170 |
Why?
|
| Humans | 28 | 2025 | 96127 | 0.170 |
Why?
|
| Brachiocephalic Veins | 1 | 2021 | 33 | 0.170 |
Why?
|
| Hospital Units | 1 | 2020 | 29 | 0.170 |
Why?
|
| Radiology Department, Hospital | 1 | 2020 | 24 | 0.160 |
Why?
|
| Catheterization, Peripheral | 1 | 2021 | 64 | 0.160 |
Why?
|
| Female | 17 | 2025 | 50063 | 0.160 |
Why?
|
| Hepatic Artery | 1 | 2021 | 84 | 0.160 |
Why?
|
| Aneurysm, False | 1 | 2020 | 55 | 0.160 |
Why?
|
| Appointments and Schedules | 1 | 2020 | 59 | 0.160 |
Why?
|
| Vascular System Injuries | 1 | 2020 | 37 | 0.160 |
Why?
|
| Radiology Information Systems | 1 | 2020 | 78 | 0.160 |
Why?
|
| Time Factors | 7 | 2025 | 5585 | 0.160 |
Why?
|
| Brachytherapy | 1 | 2021 | 127 | 0.160 |
Why?
|
| Work-Life Balance | 1 | 2019 | 7 | 0.150 |
Why?
|
| Disease Progression | 1 | 2024 | 1568 | 0.150 |
Why?
|
| Sexism | 1 | 2019 | 57 | 0.150 |
Why?
|
| Retrospective Studies | 11 | 2024 | 10286 | 0.140 |
Why?
|
| Mentors | 1 | 2019 | 101 | 0.140 |
Why?
|
| Social Media | 1 | 2020 | 111 | 0.140 |
Why?
|
| Medicare | 1 | 2021 | 458 | 0.140 |
Why?
|
| Hemorrhage | 1 | 2019 | 294 | 0.130 |
Why?
|
| Hemodynamics | 1 | 2021 | 781 | 0.130 |
Why?
|
| Motivation | 1 | 2020 | 310 | 0.130 |
Why?
|
| Male | 14 | 2025 | 45870 | 0.130 |
Why?
|
| Computer Simulation | 1 | 2021 | 1158 | 0.130 |
Why?
|
| Middle Aged | 13 | 2025 | 28363 | 0.130 |
Why?
|
| Risk Factors | 6 | 2025 | 5960 | 0.120 |
Why?
|
| Fluoroscopy | 3 | 2024 | 138 | 0.120 |
Why?
|
| Societies, Medical | 1 | 2020 | 644 | 0.120 |
Why?
|
| Sex Factors | 1 | 2019 | 1133 | 0.120 |
Why?
|
| Mesenteric Arteries | 1 | 2015 | 29 | 0.120 |
Why?
|
| Diagnostic Imaging | 1 | 2019 | 475 | 0.120 |
Why?
|
| Stents | 2 | 2020 | 425 | 0.110 |
Why?
|
| Prosthesis Design | 4 | 2019 | 310 | 0.110 |
Why?
|
| Aged | 11 | 2024 | 20964 | 0.110 |
Why?
|
| Prosthesis Failure | 1 | 2014 | 125 | 0.110 |
Why?
|
| Aged, 80 and over | 6 | 2024 | 7232 | 0.100 |
Why?
|
| Postoperative Complications | 2 | 2015 | 2591 | 0.100 |
Why?
|
| Catheters, Indwelling | 2 | 2013 | 113 | 0.100 |
Why?
|
| Catheterization, Central Venous | 2 | 2013 | 120 | 0.090 |
Why?
|
| Endoleak | 1 | 2012 | 42 | 0.090 |
Why?
|
| Hemostatics | 1 | 2012 | 61 | 0.090 |
Why?
|
| Young Adult | 5 | 2025 | 7025 | 0.090 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2012 | 121 | 0.080 |
Why?
|
| Venous Thrombosis | 1 | 2013 | 257 | 0.080 |
Why?
|
| Risk Assessment | 3 | 2025 | 2480 | 0.080 |
Why?
|
| Adult | 8 | 2025 | 28718 | 0.080 |
Why?
|
| Chicago | 3 | 2019 | 1503 | 0.070 |
Why?
|
| Adolescent | 4 | 2025 | 9896 | 0.070 |
Why?
|
| Heart-Assist Devices | 1 | 2015 | 898 | 0.070 |
Why?
|
| Constriction, Pathologic | 2 | 2021 | 220 | 0.060 |
Why?
|
| Liver Transplantation | 1 | 2013 | 1201 | 0.060 |
Why?
|
| Kidney Failure, Chronic | 1 | 2009 | 432 | 0.060 |
Why?
|
| Phlebography | 2 | 2016 | 67 | 0.060 |
Why?
|
| SEER Program | 1 | 2024 | 235 | 0.050 |
Why?
|
| Operative Time | 1 | 2024 | 167 | 0.050 |
Why?
|
| Propensity Score | 1 | 2022 | 180 | 0.040 |
Why?
|
| Pulsatile Flow | 1 | 2021 | 52 | 0.040 |
Why?
|
| Brachial Artery | 1 | 2021 | 36 | 0.040 |
Why?
|
| Microwaves | 1 | 2021 | 32 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 3927 | 0.040 |
Why?
|
| Retreatment | 1 | 2021 | 106 | 0.040 |
Why?
|
| Blood Flow Velocity | 1 | 2021 | 202 | 0.040 |
Why?
|
| Efficiency, Organizational | 1 | 2020 | 55 | 0.040 |
Why?
|
| Mechanical Thrombolysis | 1 | 2020 | 18 | 0.040 |
Why?
|
| Workflow | 1 | 2020 | 80 | 0.040 |
Why?
|
| Angioplasty, Balloon | 1 | 2020 | 100 | 0.040 |
Why?
|
| United States | 2 | 2024 | 7767 | 0.040 |
Why?
|
| Hypotension | 1 | 2020 | 76 | 0.040 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2019 | 38 | 0.040 |
Why?
|
| Radiation Exposure | 1 | 2019 | 25 | 0.040 |
Why?
|
| Congresses as Topic | 1 | 2020 | 125 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2015 | 2040 | 0.040 |
Why?
|
| Contrast Media | 1 | 2024 | 1096 | 0.040 |
Why?
|
| Mortality | 1 | 2020 | 154 | 0.040 |
Why?
|
| Radiation Dosage | 1 | 2019 | 236 | 0.040 |
Why?
|
| Anesthesia, General | 1 | 2019 | 127 | 0.040 |
Why?
|
| Aspirin | 1 | 2019 | 169 | 0.030 |
Why?
|
| Thrombectomy | 1 | 2020 | 220 | 0.030 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2020 | 167 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2021 | 2781 | 0.030 |
Why?
|
| Thrombolytic Therapy | 1 | 2020 | 261 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2015 | 2883 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 249 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2021 | 630 | 0.030 |
Why?
|
| Recurrence | 1 | 2020 | 1218 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 935 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2020 | 463 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 1469 | 0.030 |
Why?
|
| Models, Biological | 1 | 2021 | 1815 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2015 | 171 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 1981 | 0.030 |
Why?
|
| Sampling Studies | 1 | 2013 | 76 | 0.020 |
Why?
|
| Survival Rate | 1 | 2015 | 1986 | 0.020 |
Why?
|
| Incidence | 1 | 2015 | 1715 | 0.020 |
Why?
|